Drug Shortage Report for FETZIMA
| Report ID | 84779 |
| Drug Identification Number | 02440997 |
| Brand name | FETZIMA |
| Common or Proper name | FETZIMA 80MG CAP 30 CA |
| Company Name | ALLERGAN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOMILNACIPRAN |
| Strength(s) | 80MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | FETZIMA 80MG CAP 30 CA |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-05-24 |
| Actual start date | 2019-05-24 |
| Estimated end date | 2019-06-05 |
| Actual end date | 2019-06-06 |
| Shortage status | Resolved |
| Updated date | 2019-06-07 |
| Company comments | Potential issue with the label |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2019-06-07 | French | Compare |
| v11 | 2019-06-06 | English | Compare |
| v10 | 2019-06-06 | French | Compare |
| v9 | 2019-06-06 | English | Compare |
| v8 | 2019-06-06 | French | Compare |
| v7 | 2019-06-06 | English | Compare |
| v6 | 2019-06-06 | French | Compare |
| v5 | 2019-06-06 | English | Compare |
| v4 | 2019-05-27 | French | Compare |
| v3 | 2019-05-27 | English | Compare |
| v2 | 2019-05-25 | French | Compare |
| v1 | 2019-05-25 | English | Compare |
Showing 1 to 12 of 12